• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

WTO chief says vaccine manufacturers must not leave out poorer countries

By
Marco Quiroz-Gutierrez
Marco Quiroz-Gutierrez
Down Arrow Button Icon
By
Marco Quiroz-Gutierrez
Marco Quiroz-Gutierrez
Down Arrow Button Icon
April 1, 2021, 3:58 PM ET
Director-General of the World Trade Organisation Ngozi Okonjo-Iweala.
Director-General of the World Trade Organisation Ngozi Okonjo-Iweala.Salvatore Di Nolfi—Keystone/AFP/Getty Images

The head of the World Trade Organization cautioned COVID-19 vaccine manufacturers Thursday not to leave out poorer countries when it comes to vaccine distribution.

Dr. Ngozi Okonjo-Iweala said vaccine manufacturers should make enough of the COVID-19 shot for the world or license their technology to developing nations.

“It’s valid to have people want a return on their investment,” she told the BBC. “I think during times of pandemics we have to modify this somewhat, to give greater access.”

The WTO chief pointed to AstraZeneca’s recent licensing agreement with a large vaccine manufacturer in India as an example for other pharmaceutical companies to follow.

The Serum Institute of India, AstraZeneca’s partner and the world’s largest vaccine manufacturer said in February it would prioritize injections for India before the rest of the world.

Okonjo-Iweala became director general of the WTO earlier this month, becoming the global trade organization’s first woman and first African chosen as Director-General. She told the BBC there have been disagreements between WTO members on whether to relax intellectual property rights so more drug manufacturers can make COVID-19 vaccines. 

“I’m very concerned,” she said to the BBC. “The kind of inequities we see in vaccine access are really not acceptable, you can’t have a situation in which, you know, 10 countries have administered 70% of vaccine doses in the world, and there are countries that don’t have one single dose.”

In January, the AstraZeneca/ Oxford University COVID-19 shot was granted emergency use authorization in many of the world’s developing nations, including Morocco, India, and Mexico. The company said last week, according to Reuters, that 29 million doses of COVID-19 vaccine from a plant in Italy were destined for the European Union and poorer countries via the World Health Organization’s COVAX effort to vaccinate people in developing nations. 

In the U.S., President Joe Biden is facing increasing pressure from Democrats to make sure people in developing nations get vaccinated. Biden promised $4 billion in February to improve vaccine distribution to poorer nations, as well as pledged to give Mexico and Canada some of the country’s supply of the AstraZeneca vaccine.

More than 552 million COVID-19 vaccine doses have been distributed worldwide, but three-fourths have gone to only 10 countries, according to the New York Times.

New cases for COVID-19 rose globally for a fifth consecutive week, with about 3.8 million new cases reported in the last week, according to the World Health Organization. Deaths also rose for the second consecutive week, increasing by 5% or about 64,000 deaths worldwide.

About the Author
By Marco Quiroz-Gutierrez
See full bioRight Arrow Button Icon

Latest in Health

Best protein lead image
HealthDietary Supplements
The 8 Best Protein Powders of 2025: How to Choose, According to an RD
By Christina SnyderDecember 9, 2025
15 hours ago
Transparent Labs Creatine HMB as best creatine
HealthDietary Supplements
The Best Creatine Supplements of 2025: Tested and Approved
By Christina SnyderDecember 9, 2025
15 hours ago
Jon Rosemberg
CommentaryProductivity
The cult of productivity is killing us
By Jon RosembergDecember 9, 2025
19 hours ago
Trump
CommentaryTariffs and trade
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
By Bob Kocher, Bryan Roberts and Siobhan Nolan ManginiDecember 9, 2025
19 hours ago
Kevin Kiley
PoliticsElections
‘It absolutely matters politically’: Swing-district Republicans alarmed at spiking health insurance premiums tipping midterms
By Marc Levy, Kevin Freking and The Associated PressDecember 8, 2025
2 days ago
HealthHealth
These toxic wild mushrooms have caused a deadly outbreak of poisoning in California
By The Associated PressDecember 7, 2025
3 days ago

Most Popular

placeholder alt text
Success
When David Ellison was 13, his billionaire father Larry bought him a plane. He competed in air shows before leaving it to become a Hollywood executive
By Dave SmithDecember 9, 2025
22 hours ago
placeholder alt text
Economy
‘Fodder for a recession’: Top economist Mark Zandi warns about so many Americans ‘already living on the financial edge’ in a K-shaped economy 
By Eva RoytburgDecember 9, 2025
12 hours ago
placeholder alt text
Banking
Jamie Dimon taps Jeff Bezos, Michael Dell, and Ford CEO Jim Farley to advise JPMorgan's $1.5 trillion national security initiative
By Nino PaoliDecember 9, 2025
13 hours ago
placeholder alt text
Success
Craigslist founder signs the Giving Pledge, and his fortune will go to military families, fighting cyberattacks—and a pigeon rescue
By Sydney LakeDecember 8, 2025
2 days ago
placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
4 days ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
14 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.